Company intelligence / Profile preview

GenuForm AI

Ownership: Private
Development stage: Preclinical

Overview

GenuForm AI has developed an artificial intelligence platform that optimizes the geometric matching of donor and recipient knee cartilage using MR images. The technology enables more efficient and precise knee cartilage transplantation by recommending which part of a donor’s cartilage best fits each recipient. In their first trial operation, the patient fully regained knee function, reportedly for life.

Therapeutic areas: Rheumatology
Modalities: DeviceSoftware
Industry: Medical Imaging

Beyond the preview

Go deeper on GenuForm AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenuForm AI.

Explore the full profile